DOX BLUECHIP_DIP Signal

BUY BLUECHIP_DIP Open Regular · 1.00%
Technology · MARKET_PERFORM · Bull Market · BLUECHIP_DIP
3/7 Quality
Entry
$60.42
Stop Loss
$57.40
TP1
$75.53
TP2
$79.71
R:R
5.00

Analyst vs AI Verdict

ALIGNED
Wall Street
63.6% Buy Rating
4
Str.Buy
3
Buy
4
Hold
0
Sell
0
Str.Sell
11 analysts · Sept. 1, 2026
AI Expert Panel
BUY
ChatGPT BUY
Gemini BUY
Claude SKIP
Grok SKIP

Price Chart

Entry Reason

Drawdown 30% (within range) | Significant drawdown 30% | Price < SMA200 (deep dip) | RSI oversold (52)

Entry Technical Conditions

Methodology →
RSI
52.1
Neutral
ADX
38.8
Trending
Volume
0.03x
Low
BB Pos
0.46
Mid
ATR %
2.7%
Normal

AI Expert Panel

BUY
ChatGPT BUY ⏳ Pending

Price action: DOX has logged a meaningful rebound from mid-2026 lows and, at 60.42, sits near a near-term support zone with recent closes above 60, while facing resistance around 63-64; a breakout above that band could push toward 65-67 in the near term. Entry at current price offers a reasonable swing setup given the recent momentum and established support level. Fundamentals: the company shows solid profitability metrics (ROE 15.9%, net margin 11.8%), reasonable valuation (P/E 11.4, P/B 2.59) and a 3.88% dividend, with a low beta of 0.44 indicating relatively lower market-driven swings. Risks: in a 2-12 week window, tech sector volatility, flat/restrained revenue growth (3Y -0.3%, 5Y +1.7%), a current ratio near 1, and potential multiple compression or macro headwinds could cap upside. Upside potential: a move back toward the 65-67 zone implies roughly 8-12% upside from 60.42, with a break above 64-65 potentially opening room toward the mid-70s if momentum sustains.

Gemini BUY ⏳ Pending

DOX is currently showing signs of a constructive recovery, having successfully established a higher low above the $50 support level observed in late June and July. The stock has recently reclaimed the $60 level, indicating a shift in momentum as it attempts to build a base for a potential move back toward the $65-$68 range. Fundamentally, the company remains stable with a low P/E ratio of 11.4 and a solid dividend yield of 3.88%, which provides a defensive cushion for swing traders during periods of market volatility. Key risks include the stagnant revenue growth and the potential for broader sector weakness to drag the stock back toward its recent lows, but the current risk-to-reward profile is favorable for a 2-12 week trade with an estimated upside potential of 10-15%.

Claude SKIP ⏳ Pending

DOX is currently at $60.42, down approximately 29% from its 52-week high of $84.95 (September 2025), indicating a severe downtrend that has persisted for nearly a year with no clear reversal pattern emerging. The price action shows repeated failed bounces throughout 2026—every rally attempt (e.g., June's $65.26 high, August's $64.32 high) has been sold off, suggesting weak institutional support and ongoing negative sentiment that could continue pressuring the stock. While the fundamentals appear reasonable on the surface (P/E of 11.4, ROE of 15.9%, 3.88% dividend yield), the concerning current ratio of 0.98 and stagnant 3-year revenue growth of -0.3% suggest operational challenges, and the stock's inability to hold gains despite a 3.88% dividend yield indicates fundamental concerns that the market is pricing in. For a 2-12 week swing trade, the lack of a clear technical bounce-back setup, combined with the stock's demonstrated weakness to break below support levels repeatedly, presents unfavorable risk-reward; the downside risk to $50-55 appears greater than upside potential to $65-68 in this timeframe.

Grok SKIP ⏳ Pending

The price action shows a clear multi-month downtrend from the $84 area in late 2025 down to the current $60.42, with the most recent weekly candle closing lower after failing to sustain gains above $63; this does not present a strong entry point for a 2-12 week swing as momentum remains weak. Fundamentals are mixed at best, with an attractive low P/E of 11.4 and 3.88% dividend yield offset by negative 3-year revenue growth, a current ratio below 1 indicating liquidity pressure, and only modest ROE. Key risks over the next 2-12 weeks include further downside if the stock retests the June lows near $51 amid broader tech sector weakness or disappointing earnings, plus low beta offering limited volatility for quick swings. Overall the verdict is SKIP as there is insufficient evidence of an imminent upward move, with estimated upside potential limited to perhaps 5-8% before resistance at $65-67.

Fundamentals Trend

Metric 2025-11-032025-12-032026-01-022026-05-172026-08-112026-08-12
ROE (TTM) 16.0%16.0%16.0%16.5%15.9%15.9%
P/E (TTM) 16.7014.8915.6611.4111.4411.44
Net Margin 11.9%11.9%11.9%12.5%11.8%11.8%
Gross Margin 37.2%37.2%37.2%37.6%37.8%37.8%
D/E Ratio 18.4618.4618.46
Current Ratio 1.221.221.221.060.980.98

Company Summary

Amdocs Limited, through its subsidiaries, provides software and services to communications, entertainment, media, and other service providers worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud offering. The company also provides CES25, a telco-native, GenAI-led customer experience suite, spanning business, and operations and network domains that is embedded with AI and related tools. In addition, it offers GenAI agents, and which include Customer Engagement Platform, a telecom-specific customer relationship management (CRM) solution; Amdocs Monetization Suite which enables customers to monetize their broad set of services and offerings; Amdocs Intelligent Networking Suite, a set of solutions that provide end-to-end service orchestration; Amdocs Charging; Amdocs eSIM Cloud that enables service providers to offer digital SIM (eSIM); Amdocs MarketONE, a based Software-as-a-Service (SaaS)-based platform that includes pre-integrated digital services, ranging from media, gaming, eLearning, sports and retail to security, and business services; and Amdocs connectX, a cloud-native telco-in-a-box software-as-a-service platform for digital telecom brands, as well as Amdocs CatalogONE that spans the entire CES25 suite and combines embedded business intelligence with telecom-specific GenAI agents. Further, the company provides consulting, experience design, data, cloud, network services, delivery, quality engineering, operations, systems integration, and content services to various platforms and technologies; maintenance, enhancement design and development, and operational support services; network deployment and optimization services; and managed services, including AI and related tools, predictive analytics, and robotic process automation, as well as quality engineering, mobile network, cloud, and professional services. Amdocs Limited was founded in 1982 and is headquartered in Saint Louis, Missouri.

View full stock profile →

More Signals for DOX

View all →

Disclaimer: This is an automated trading signal generated by AI analysis. It is not financial advice. Always do your own research before making investment decisions. Past performance does not guarantee future results.